Showing results (111-120 of 226) with videos related to

Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|May 10, 2013
Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metaboliteA M Filppula, A Tornio, M Niemi, et al.
Basic & Clinical Pharmacology & Toxicology|May 4, 2013
Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration--an experimental intoxication study in pigsJuho A Heinonen, Erik Litonius, Janne T Backman, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
Triazolam is ineffective in patients taking rifampinK Villikka, K T Kivistö, J T Backman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
Pharmacogenetics and Genomics|May 29, 2015
SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acidAleksi Tornio, Juha Vakkilainen, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastT Karonen, A Filppula, J Laitila, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
Plasma concentrations of active simvastatin acid are increased by gemfibrozilJ T Backman, C Kyrklund, K T Kivistö, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolamJ T Backman, J S Wang, X Wen, et al.
British Journal of Clinical Pharmacology|December 12, 2001
In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)X Wen, J S Wang, K T Kivistö, et al.
Clinical Pharmacokinetics|July 29, 2003
Pharmacokinetic interactions with rifampicin : clinical relevanceMikko Niemi, Janne T Backman, Martin F Fromm, et al.
Pageof 23